Skip to content
August 15, 2022


Investment information for the new generation


Abbott Laboratories (ABT.NYSE) announced their FreeStyle Libre system, a sensor-based glucose monitoring tech, is now being used in hospitals setting during the COVID-19 pandemic. This will make it easier…
Abbott Laboratories (ABT.NYSE) received Food and Drug Administration (FDA) approval for a new alternative surgical technique for Abbott’s HeartMate 3 heart pump that would allow for more advanced heart…